Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos A Zarate

Showing results (1-10 of 454) with videos related to

Pageof 46
Sort By:
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|May 14, 2020
Ketamine: a new chapter in antidepressant developmentCarlos A Zarate
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|March 19, 2021
Commentary on the Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive DisorderCarlos A Zarate
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|January 14, 2023
Key considerations for clinical trials in psychopharmacologyCarlos A Zarate
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|September 24, 2017
What Should be Done When Elderly Patients with Major Depression Have Failed to Respond to All Treatments?Carlos A Zarate
CNS Spectrums|May 23, 2013
New insights into the neurobiology, diagnosis, and treatment of mood disordersCarlos A Zarate
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 27, 2021
Glutamate modulators and beyond: A neuroscience revolution in the makingCarlos A Zarate
Biological Psychiatry|October 16, 2010
Magnetic resonance spectroscopy studies of the glutamatergic system in mood disorders: a pathway to diagnosis, novel therapeutics, and personalized medicine?Giacomo Salvadore, Carlos A Zarate
Current Psychiatry Reports|November 5, 2008
A review of the preclinical and clinical evidence for protein kinase C as a target for drug development for bipolar disorderNancy DiazGranados, Carlos A Zarate
The American Journal of Psychiatry|January 2, 2004
Double-blind comparison of the continued use of antipsychotic treatment versus its discontinuation in remitted manic patientsCarlos A Zarate, Mauricio Tohen
Current Psychiatry Reports|January 29, 2008
The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effectsSungho Maeng, Carlos A Zarate
Pageof 46

Showing results (1-10 of 454) with videos related to

Sort By:
Pageof 46
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|May 14, 2020
Ketamine: a new chapter in antidepressant developmentCarlos A Zarate
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|March 19, 2021
Commentary on the Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive DisorderCarlos A Zarate
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|January 14, 2023
Key considerations for clinical trials in psychopharmacologyCarlos A Zarate
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|September 24, 2017
What Should be Done When Elderly Patients with Major Depression Have Failed to Respond to All Treatments?Carlos A Zarate
CNS Spectrums|May 23, 2013
New insights into the neurobiology, diagnosis, and treatment of mood disordersCarlos A Zarate
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 27, 2021
Glutamate modulators and beyond: A neuroscience revolution in the makingCarlos A Zarate
Biological Psychiatry|October 16, 2010
Magnetic resonance spectroscopy studies of the glutamatergic system in mood disorders: a pathway to diagnosis, novel therapeutics, and personalized medicine?Giacomo Salvadore, Carlos A Zarate
Current Psychiatry Reports|November 5, 2008
A review of the preclinical and clinical evidence for protein kinase C as a target for drug development for bipolar disorderNancy DiazGranados, Carlos A Zarate
The American Journal of Psychiatry|January 2, 2004
Double-blind comparison of the continued use of antipsychotic treatment versus its discontinuation in remitted manic patientsCarlos A Zarate, Mauricio Tohen
Current Psychiatry Reports|January 29, 2008
The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effectsSungho Maeng, Carlos A Zarate
Pageof 46